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Broad-spectrum amino-acid racemases (Bsrs) enable bacteria
to generate noncanonical d-amino acids, the roles of which
in microbial physiology, including the modulation of cell-wall
structure and the dissolution of biofilms, are just beginning to
be appreciated. Here, extensive crystallographic, mutational,
biochemical and bioinformatic studies were used to define the
molecular features of the racemase BsrV that enable this
enzyme to accommodate more diverse substrates than the
related PLP-dependent alanine racemases. Conserved resi-
dues were identified that distinguish BsrVand a newly defined
family of broad-spectrum racemases from alanine racemases,
and these residues were found to be key mediators of the
multispecificity of BrsV. Finally, the structural analysis of an
additional Bsr that was identified in the bioinformatic analysis
confirmed that the distinguishing features of BrsV are
conserved among Bsr family members.
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1. Introduction
In nature, the majority of d-amino acids (DAA) are found in
bacterial cell walls, where d-Ala and d-Glu are key constitu-
ents of the short peptides that cross-link the glycan chains
within the peptidoglycan (PG) polymer (Vollmer et al., 2008).
These DAA are produced from their corresponding l-enan-
tiomers by highly specific alanine and glutamate amino-acid
racemases (Alr and MurI), which have distinct structural and
catalytic properties (Cava, Lam et al., 2011). Alr (EC 5.1.1.1),
which is the best characterized of these enzymes, is a
cytoplasmic protein that requires the ubiquitous coenzyme
pyroxidal-5-phosphate (PLP) as a cofactor (Richard et al.,
2009). Crystallographic studies of Alr from diverse organisms
have enabled the identification of the structural determinants
and spatial constrains that account for its mono-specificity
(Coun˜ago et al., 2009; LeMagueres et al., 2003, 2005; Noda et
al., 2004; Shaw et al., 1997; Strych & Benedik, 2002; Wu et al.,
2008).
Recently, we demonstrated that diverse bacteria produce
and release to the extracellular medium high amounts of DAA
that are not canonical components of the cell wall (e.g. d-Ala
and d-Glu; Cava, de Pedro et al., 2011; Lam et al., 2009). In
Vibrio cholerae, the production of these noncanonical DAA
(NCDAA) is dependent upon BsrV (VC1312), a periplasmic
broad-spectrum racemase (Bsr) with high sequence homology
(E-value of 1  1025, 28% identity) to the primary alanine
racemase of V. cholerae, AlrV (VC0372; Fig. 1a and Supple-
mentary Fig. S1a1 Lam et al., 2009). A subset of Alr-related
racemases from other organisms have also been reported to
accept multiple amino-acid substrates (Kino et al., 2007; Lam
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: DW5071).
research papers
80 Espaillat et al.  New family of amino-acid racemases Acta Cryst. (2014). D70, 79–90
et al., 2009; Matsui & Oikawa, 2010; Wu et al., 2008). In
V. cholerae, the presence of NCDAA negatively regulates cell-
wall metabolism, at least in part owing to their incoporation
into PG (Cava, de Pedro et al., 2011; Cava, Lam et al., 2011;
Lam et al., 2009). NCDAA have also been reported to influ-
ence biofilm stability (Kolodkin-Gal et al., 2010), virulence
(Anfora et al., 2007) and sporulation (O’Connor & Zusman,
1997). Susceptibility to NCDAA seems to be more widespread
than production of NCDAA, raising the possibility that some
bacteria may produce and release NCDAA in order to influ-
ence nonproducing species within the same habitat (Cava, de
Pedro et al., 2011; Horcajo et al., 2012). Given the important
adaptative properties provided by NCDAA, a detailed
investigation of multi-specific racemases will be critical to
understand NCDAA-controlled processes and for the devel-
opment of new drugs to combact pathogenic bacteria (Conti et
al., 2011).
Here, we explore the capacity of BsrV to utilize a wide
variety of substrates using a combination of structural,
biochemical, mutational and bioinformatic approaches.
Finally, we also define and experimentally validate a molecular
footprint of conserved residues that mediate the multi-
specificity of BrsVand use this signature sequence to identify a
large family of BsrV-like multi-specific racemases in bacteria.
2. Materials and methods
2.1. Microbiology
All V. cholerae strains used in this study were derived from
the sequenced El Tor clinical isolate N16961 (Heidelberg et al.,
2000). Plasmids and primers, growth conditions and standard
molecular-biology techniques are described in the Supporting
Information.
2.2. Racemase activity assays
All racemase assays were performed in two fundamental
steps: (i) the racemase reaction and (ii) the DAAO reaction
coupled to peroxidase and 2,3-diaminophenazine or Marfey’s
(FDAA) derivatization (Fig. 1b). The formation of the
colorimetric product was measured at 492 nm (see Supporting
Information). The steady-state kinetics parameters were
determined usingMicrosoft Office 2007 and Solver Macro (De
Levie, 2001; see Supporting Information). For competition
assays, FDAA derivatization of l and d forms of amino acids
Figure 1
Biochemical comparison of AlrV and BsrV from V. cholerae. (a) Predicted protein features of the monospecific alanine racemase (AlrV) and broad-
spectrum racemase (BsrV) from V. cholerae generated with the NCBI protein-analysis package. Dimerization motifs are in yellow. SP, signal peptide.
Red circles pinpoint the catalytic Lys and Tyr residues. Vertical lines correspond to conserved functional residues (PLP binding, substrate binding,
catalytic site and dimeric interface). (b) Schematic of the different methods used to assess amino-acid racemase activities (see x2). (c, d) d-Amino-acid
accumulation in the presence of AlrV (c) and BsrV (d) after 90 min reactions with various substrates revealed through Marfey’s derivatization. The
results in (c) and (d) are the means  SD of triplicates from two independent experiments. See also Supplementary Fig. S1.
and HPLC analysis was performed (see Supporting Informa-
tion).
2.3. Structural determination
Crystallization of BsrV, an R173N174/AA point mutant (Cl-
BsrV), Aeromonas hydrophila Alr3 (a putative Bsr, renamed
BsrAh) and the putative primary alanine racemase from
A. hydrophila (AlrAh) was performed using a high-throughput
NanoDrop ExtY robot (Innovadyne Technologies Inc.) and
the commercial Qiagen screens The JCSG+ Suite and The
PACT Suite and the Hampton Research screens Index, Crystal
Screen and Crystal Screen 2 following the sitting-drop vapour-
diffusion method (see Supporting Information). X-ray data
collection was performed at a synchrotron-radiation facility on
beamlines ID29 and ID14-4 at the ESRF, Grenoble, France or
on the X06SA beamline at SLS, Villigen, Switzerland (see
Supporting Information). Data sets were collected using a
PILATUS 6M or a Q315r ADSC X-ray detector, and were
processed usingXDS (Kabsch, 2010) and scaled using SCALA
(Evans, 2006) from the CCP4 suite (Winn et al., 2011). The
structure was solved by the molecular-replacement method
with MOLREP (Vagin & Teplyakov, 2010) from the CCP4
suite and was refined with PHENIX (Adams et al., 2010) and
manually improved using Coot (Emsley & Cowtan, 2004; see
Supporting Information). The stereochemistry of the models
was verified using MolProbity (Chen et al., 2010).
2.4. Bioinformatic analyses
The identification of new putative broad-spectrum race-
mases and the residues responsible for substrate specificity
was performed by searching with BLAST (Altschul et al.,
1997) against a nonredundant protein database and filtering,
selecting only those mapped onto the UniProt database. The
protein data set was aligned using MUSCLE (Edgar, 2004;
v.3.8.31). The resulting multiple sequence alignment was
filtered using the Jalview (Waterhouse et al., 2009) tool (v.2.7).
The identification of specificity-determining positions (SDPs)
was carried out using the JDet package (see Supporting
Information).
2.5. Accession numbers
The atomic coordinates and structure factors for BsrV,Cl-
BsrV mutant, BsrAh and AlrAh (PDB entries 4beu, 4beq, 4bf5
and 4bhy, respectively) have been deposited in the Protein
Data Bank, Research Collaboratory for Structural Bioinfor-
matics, Rutgers University, New Brunswick, New Jersey, USA
(http://www.rcsb.org/).
3. Results
3.1. BsrV is a promiscuous paralogue of the V. cholerae
alanine racemase AlrV
Comparisons of the substrate specificities of BsrVand AlrV,
the presumed alanine-specific racemase from V. cholerae,
revealed that BsrV is able to utilize a much broader range
of substrates (Figs. 1b, 1c and 1d). Unlike AlrV, which only
catalyzes the interconversion of l-Ala and l-Ser and their
corresponding d forms (Fig. 1c and Supplementary Fig. S1b),
BsrV reversibly racemizes ten of the 19 natural chiral amino
acids known, including both non--branching aliphatic amino
acids (Ala, Leu, Met, Ser, Cys, Gln and Asn) and positively
charged amino acids (His, Lys and Arg) (Fig. 1d and Supple-
mentary Figs. S1c and S1d). Additionally, it catalyzes the
racemization of several amino acids that are not typically
incorporated into proteins (Supplementary Fig. S1e).
However, BsrV did not alter the chirality of negatively
charged (i.e. Glu and Asp) or aromatic (i.e. Tyr, Trp and
Phe) amino acids and displayed minimal activity towards
-branched aliphatic (i.e. Ile, Val and Thr) potential substrates
(Fig. 1d).
3.2. Reaction kinetics of BsrV and AlrV
Kinetic analyses, using individual and pooled substrates,
were also performed in order to better characterize the
activities of BsrV and AlrV. Most analyses were performed
using the His-tagged mature proteins used in structural studies
because control assays performed with untagged mature BsrV
showed that the affinity tag did not alter the activity of the
enzyme (Supplementary Fig. S1f). The kinetic analyses
revealed that the catalytic efficiency of BrsV (as reflected by
kcat/Km) varies depending upon the amino-acid substrate and
suggest that it acts more readily upon lysine, arginine and
methionine than upon other substrates (Table 1). Assays using
pooled substrates largely confirmed this idea: BsrV incubated
with its ten potential l-amino-acid substrates efficiently
formed d-Arg and d-Lys, but produced lower amounts of
other DAA than when they were assayed singly (Supple-
mentary Figs. S1g and S1h). Consequently, the high produc-
tion of d-Met and d-Leu by V. cholerae in vivo (the principal
products of BrsV; Lam et al., 2009) is likely to reflect the
relatively high availability of the corresponding l-amino acids.
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Table 1
Kinetic parameters (Km, kcat and kcat/Km) of AlrV and BsrV for various
amounts (1.25–60 mM) of l-amino-acid substrates were calculated using
data obtained with 0.47 mM purified racemase (see x2).
All kinetic constants must be considered as apparent values because of the
impossibility of calculating initial enzyme velocities. The results are means 
SD of triplicates from two independent experiments. BsrV reaction kinetics
for His and Cys were not determined (ND).
Km (mM) kcat (s
1) kcat/Km (mM
1 s1)
BrsV
Ala 11  2 1.68  0.11 15.3  102
Ser 28  3 4.68  0.21 16.7  102
Met 11  2 2.94  0.04 26.7  102
Leu 30  7 2.30  0.28 7.7  102
Cys ND ND ND
Gln 22  3 2.59  0.16 11.8  102
Asn 15  4 0.05  0.004 0.3  102
His ND ND ND
Lys 9  1 4.76  0.11 52.9
Arg 18  3 5.09  0.11 28.3
AlrV
Ala 1.5  0.6 1.42  0.003 94.5
Ser 17  8 1.16  0.0002 6.8
Comparative analyses of BsrV and
AlrV reaction kinetics revealed that the
average kcat of BsrV is higher than that
of AlrV. However, the Km values for
BsrV were also around tenfold higher
than the Km of AlrV for alanine, its
preferred substrate, and consequently
kcat/Km for alanine racemization by
AlrV is higher than that of BsrV for its
substrate amino acids (Table 1). These
facts fit well with the proposal that
the development of catalytic multi-
specificity is often accompanied by a
reduction in kinetic performance
(Babtie et al., 2010; Khersonsky et al.,
2006).
3.3. The crystal structure reveals
unique structural features in BsrV
Purified BsrV was crystallized and its
structure was solved at atomic resolu-
tion (1.15 A˚; Table 2). As observed for
monospecific Alrs, BsrV folds as a
globular homodimeric enzyme in which
both monomers participate in the
elaboration of the active sites (Fig. 2a).
Analyses using the DALI server (Holm
& Rosenstro¨m, 2010) indicate that the
closest structural homologues of BsrV
are alanine racemases from Bacillus
anthracis (AlrBax; Coun˜ago et al., 2009;
r.m.sd. of 2.0 A˚ for 361 C atoms) and
E. coli (AlrEc; Wu et al., 2008; r.m.s.d. of 2.5 A˚ for 347 C

atoms). Since the crystallization of AlrV was unsuccessful,
further comparative analyses of BsrV were performed with
AlrEc (E-value of 3 10157 to AlrV; Supplementary Fig. S1a).
Superimposition of the BsrV and AlrEc structures readily
reveals their extensive similarity; nonetheless, substantial
differences are also apparent (Fig. 2b and Supplementary Figs.
S2 and S3).
The entry channel to the catalytic site is approximately
twofold wider in BsrV than in AlrEc (roughly 10  14 A˚ in
BsrV compared with 7  9.5 A˚ in AlrEc; Fig. 2b and Supple-
mentary Figs. S2b and S2c). This difference is a direct conse-
quence of shorter loops in the side walls of the catalytic entry
site in BsrV and of the different orientation of helix 10
(Fig. 2b and Supplementary Figs. S2b and S2c). In addition,
the catalytic entry site has a negative charge in BsrV but not in
AlrEc (Supplementary Fig. S2d), perhaps impeding the entry
of acidic substrates into the catalytic site and thereby contri-
buting to the selectivity of BsrV for neutral and basic amino
acids. BsrV also contains a wider tunnel connecting the entry
to the catalytic centre (the narrowest width of the BsrV tunnel
is 9.0 A˚ compared with 6.3 A˚ in AlrEc).
The structure of BrsV also differs from that of AlrEc owing
to the presence of an additional structural element formed
from the sequence at the N-terminus of the protein (residues
24APLHIDT30). These amino acids fold into a stable, hinge-
like complementary structure between monomers that shifts
their relative positions (Figs. 2b and 2c). In BsrV monomers,
the relative positions of the N-terminal domain (residues 24–
279) and the C-terminal domain (residues 280–410) are offset
by a 9 rotation compared with the equivalent domains in
AlrEc (Fig. 2c), and an average displacement of 1.5 A˚ for the
whole protein backbone is observed. Consequently, there are
dramatic differences between the disposition and conforma-
tion of the active sites of BrsV and those of AlrEc (e.g. an
increased distance between active sites from 37.6 A˚ in Alr to
45 A˚ in BsrV; Fig. 2c, right). The N-terminal structure of BrsV
appears to be important for the activity of the enzyme, since a
single mutation in this structure (P25E; Fig. 2b and Supple-
mentary S3a) completely abolishes the activity of BrsV
towards Ala and Met and dramatically impairs (70% reduc-
tion) its activity towards Arg.
3.4. The catalytic machinery of BsrV
In addition to the differences between the relative positions
of protein domains in BsrV and AlrEc, comparative structural
analyses revealed significant differences between the catalytic
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Table 2
Data-collection and refinement statistics.
Data set BsrV Cl-BsrV BsrAh AlrAh
Space group C2 C2 P21 C2221
Unit-cell parameters
a (A˚) 96.62 95.99 56.67 110.80
b (A˚) 51.09 50.99 81.85 134.74
c (A˚) 76.73 76.46 78.28 192.15
 () 90 90 90 90
 () 101.15 100.69 98.97 90
 () 90 90 90 90
X-ray source ID29, ESRF X06SA, SLS ID14-4, ESRF ID29, ESRF
Data processing
Temperature (K) 100 100 100 100
Wavelength (A˚) 0.95994 0.99987 0.93927 0.97901
Resolution (A˚) 47.3–1.15
(1.21–1.15)
44.8–1.50
(1.58–1.50)
42.1–1.45
(1.53–1.45)
48.04–3.25
(3.43–3.25)
Measured reflections 483260 428625 1150270 75325
Unique reflections 128145 57665 124710 21300
Multiplicity 3.3 (3.1) 6.7 (6.6) 7.4 (7.0) 3.5 (3.6)
Completeness (%) 98.5 (98.5) 99.0 (99.0) 99.9 (99.7) 93.3 (95.4)
Average I/(I) 11.5 (4.3) 14.7 (4.2) 12.8 (2.5) 11.5 (1.8)
Molecules in asymmetric unit 1 1 2 4
Matthews coefficient (A˚3 Da1) 2.2 2.2 1.6 2.3
Solvent content (%) 43.6 43.6 25.0 47.8
Rmerge 0.05 (0.22) 0.08 (0.47) 0.09 (0.79) 0.09 (0.68)
Refinement
Resolution range (A˚) 47.3–1.15 47.1–1.50 42.1–1.45 47.32–3.25
Total No. of atoms 6670 6396 13365 10220
No. of protein non-H atoms 3074 2976 6238 9900
No. of ions (Cl) 1 — 2 —
No. of water molecules 532 447 931 177
Rwork/Rfree 0.16/0.17 0.15/0.17 0.19/0.21 0.26/0.29
R.m.s.d., bond length (A˚) 0.010 0.010 0.004 0.009
R.m.s.d., bond angles () 1.368 1.297 0.620 1.110
Ramachandran statistics, residues in
Most favoured regions (%) 97.10 97.17 97.09 84.85
Allowed regions (%) 2.99 2.83 2.91 10.20
Disallowed regions (%) 0.25 0.0 0.0 4.95
PDB code 4beu 4beq 4bf5 4bhy
centres of the two enzymes. Notably, the enzymes use different
means to position their PLP cofactor (Fig. 3a and Supple-
mentary Fig. S3b). In BsrV, a Tyr residue that is conserved
among Alrs and is typically involved in coordination of the
phosphate moiety of PLP is replaced by a proline residue
(Pro391), thereby enlarging the space within the active site.
Phosphate coordination in BsrV instead
depends on Ser245 and Tyr208 and a
network of interactions mediated by
water molecules (Fig. 3a and Supple-
mentary Fig. S3b). No differences are
observed in the stabilization of the
pyridoxal ring, where Arg260 stabilizes
the N atom of the ring through its N"
atom (2.82 A˚).
The active site of BrsV also lacks an
N-carboxylated lysine (Kcx) that in
AlrEc and most alanine racemases
stabilizes an arginine involved in
substrate binding within the active site
(Watanabe et al., 2002). In BsrV, Kcx is
replaced by Ala165 and the substrate-
binding Arg (Arg173) is then stabilized
in the active site by the presence of an
ion (Fig. 3a and Supplementary Figs.
S3b and S3c). Its tetracoordination
(with one water molecule at 3.28 A˚, the
N2 atom of Asn174 at 3.58 A˚, the N"
atom of Arg173 at 3.67 A˚ and the N2
atom of Arg173 at 3.61 A˚) and low B
factor suggested that it was chloride
(Cl; Fig. 3a and Supplementary S3c). A
Cl ion has also been found in the
monospecific alanine racemase AlrBax;
however, unlike in BsrV, coordination
of Cl in AlrBax is mediated by the same
residues that interact with Kcx in AlrEc
and other enzymes that contain Kcx
(Coun˜ago et al., 2009). Furthermore, the
position occupied by Asn174 in BsrV
(Fig. 3a) contains hydrophobic residues
(Leu and Ile) in AlrEc, AlrBax and other
monospecific Alrs. Collectively, these
analyses provide strong evidence that
the presence of a negative charge near
the catalytic residue is critical for
amino-acid racemization by these
enzymes; however, they also illuminate
the differing catalytic environments in
the active sites of enzymes with distinct
specificities.
The relevance of the Cl to BsrV
activity was further investigated by the
structural and biochemical character-
ization of a BsrV R173N174/AA point
mutant (Cl-BsrV). As expected,
analysis of the crystal structure of
Cl-BsrV (Table 2 and Fig. 3b)
revealed that the Cl was absent.
However, the structure of Cl-BsrV
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Figure 2
Three-dimensional structure of the BsrV dimer. (a) Crystal structure of a BsrV dimer with
monomers depicted in yellow and blue. PLP molecules are shown in sticks and Cl ions are shown
as green spheres. (b) Structural superimposition of BsrV coloured as in (a) and Ala racemase from
E. coli (AlrEc) in brown. Loops L1 and L2 and -helix 10 at the entry channel are labelled [six
residues in L1 (204–210) and 11 residues in L2 (267–278) in BstV versus ten residues in L1 (159–169)
and 18 residues (216–234) in L2 in AlrEc]. On the right, differences in their active-site cavities are
shown. White arrows show the dimensions of the entrance of the BsrV cavity. At the bottom of (b),
a 180 rotation view (back side) of the dimer is shown and the BsrV N-terminal insertion is
highlighted in the box (bottom right). The position of the N-terminal residue for both monomers in
the AlrEc structure is marked by an asterisk. In the close-up view of the back-side region of BsrV,
the N-terminal insertion is shown as sticks. Polar interactions between the N-terminal extensions
from both monomers are represented as dotted lines. The position of Pro25 is indicated by a red
arrow.
was otherwise very similar to that of BsrV; the only minor
changes observed were in the side chains of Tyr208 and His204
(Fig. 3b). As anticipated, Cl-BsrV had a highly reduced or
no ability to racemize most amino acids (Fig. 3c and Supple-
mentary Figs. S3d and S3e), consistent with Cl and Arg173
serving to replace Kcx in stabilizing a variety of substrates in
the active site of BsrV.
3.5. Identification of molecular signatures that distinguish
BsrV-like and Alr-like racemases
We hypothesized that the basis for the broad substrate
tolerance of BsrV might be recognizable through sequence
analysis and therefore searched for a molecular footprint of
residues that are conserved among BsrV-like enzymes and
differ from those found in monospecific alanine racemases.
To initiate this analysis, a representative, nonredundant, set of
PLP-dependent amino-acid racemase sequences (Alr and Bsr)
from different bacteria were collected and aligned. Multiple
sequence alignment (MSA; see x2) revealed differential
conservation patterns that allowed clustering of proteins into
three subfamilies (Fig. 4a). Subfamily 1 (in red) is composed of
84 proteins and includes AlrV, AlrEc and Alr2 (DadB) from
E. coli, which have been experimentally confirmed as alanine-
specific racemases (Fig. 1c; Faraci & Walsh, 1988; Lam et al.,
2009). Subfamily 2 (in blue) is comprised of 13 proteins,
including BsrV (Alr2 from V. cholerae). Of the remaining 39
proteins in the data set, 24 proteins were grouped as subfamily
3 (in green). The 15 outlier proteins (in black) could not be
assigned to any of the subfamilies (Fig. 4a). Based on the
grouping of the characterized racemases, we assumed that the
proteins in subfamily 1 are monospecific alanine racemases,
while the proteins in subfamily 2 have a broader substrate
spectrum. As no member of subfamily 3 or any of the 15
outlier proteins has been biochemically characterized,
these proteins were not considered for further sequence
analysis.
Further comparative analyses of subfamilies 1 and 2 (see
Supporting Information) enabled the prediction of an initial
set of 31 specificity-determining positions (SDPs) that
appeared to typify the specific and broad-spectrum racemase
subfamilies. After additional refinement with manual inspec-
tion of each potential SDP, this approach allowed the selection
of 16 sites within these enzymes that appear to constitute a
molecular footprint that can be used to distinguish alanine and
broad-spectrum racemases (Fig. 4b; discussed further below).
Mapping of the broad-spectrum-linked amino-acid loci to the
BsrV structure revealed that these amino acids affect or reside
within features that distinguish BsrV from AlrV, including
placement of the entry sites (Arg119 and Arg121), the size of
the catalytic entry site (Pro206, Tyr208, Lys216 and Tyr246)
and the catalytic machinery (Cys70, Ala165, Asn167, Gly169,
Asn174, Gly263, Asn348, Thr349
and Pro391; see Fig. 5h). Notably,
specificity determinants were not
found within the N-terminal
extension of BsrV, although all of
the putative broad-spectrum
enzymes appear to possess this
signature in the mature protein
(relative to Alrs) as well as a
putative signal sequence
(Supplementary Table S3).
An expanded data set
containing 2540 putative PLP
racemases was similarly grouped
into subfamilies and the identities
of these families were determined
based on the enrichment of
proteins described as ‘broad-
spectrum’ or ‘specific’ racemases
in the previous analysis (see
Supplementary Material). This
strategy resulted in the identifi-
cation of 74 BsrV-like racemases
that had probably been mis-
annotated previously as being
specific racemases. Intriguingly,
most Bsr candidates are found in
Gram-negative marine bacteria,
primarily (54.5%) in members
of the Vibrionaceae family
(Supplementary Table S4).
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Figure 2 (continued)
(c) Different oligomeric arrangement between BsrV and AlrEc and its effect on the spatial distribution of
the active sites. A schematic representation of the AlrEc and BsrV dimers is shown on the left; asterisks
mark active sites. A rotation of 9 between monomers is produced by the N-terminal insertion in BsrV.
Bottom left, structural superimposition of BsrV and AlrEc (brown cartoon). Displacement of the BsrV
structural core by the N-terminal insertion (sticks) is represented by black arrows. Molecular surfaces for
AlrEc and BsrV are shown on the right. The positions of active sites are marked by white circles and
differences in distances and position of BsrVactive sites versusAlr are highlighted. See also Supplementary
Fig. S2.
3.6. The structure of the A. hydrophila
broad-spectrum racemase mirrors that of
BsrV
To validate our in silico identification of
putative broad-spectrum racemases, we
performed biochemical and structural char-
acterization of A. hydrophila Alr3 (a puta-
tive Bsr, renamed BsrAh) and the putative
primary alanine racemase of A. hydrophila
(AlrAh), which were identified from the
‘broad-spectrum’ and ‘specific’ subfamilies,
respectively (Figs. 4a and 4c, Table 2 and
Supplementary Fig. S4 and Table S4). As
predicted, structural comparison revealed
that AlrAh and BsrAh differ in a manner
analogous to that seen for BsrV and AlrEc
(Supplementary Fig. S4), and BsrAh exhibits
all of the distinguishing structural features
of BsrV [i.e. Cl instead of Kcx, a wider
entry channel (shorter flanking loops) for
the catalytic site, an N-terminal hinge-like
extension and conserved signature residues;
Fig. 4c and Supplementary Figs. S4d–S4h].
BsrAh also resembles BsrV in its ability to
discriminate between amino-acid substrates
and displayed catalytic activity against an
identical subset of natural amino acids
(Supplementary Figs. S4i and S4j). There-
fore, the distinct subfamilies of racemases
evident in bioinformatic analyses appear to
comprise a functionally distinct subset of
amino-acid racemases with broad substrate
specificity.
3.7. Molecular modelling of the docking of
diverse amino-acid substrates within the
BsrV and AlrBs active sites
To unveil the structural determinants that
influence substrate stabilization in specific
and broad-range racemases, we took
advantage of the crystal structure of
B. stearothermophilus alanine racemase
(AlrBs) in complex with N-(5
0-phosphopyr-
idoxyl)-d-alanine (PLP-d-Ala; Watanabe et
al., 2002; PDB entry 1l6g) as the reference
since this structure mimics the enzyme–
substrate catalytic intermediate. We super-
imposed AlrBs in complex with PLP-d-Ala
on BsrV and substituted the alanine
analogue by all of the different kinds of
amino-acid substrates, selecting the most stable conformation
in each case (Figs. 5a–5f). Whilst AlrBs could only accom-
modate alanine and serine (not shown) in its catalytic site
(Figs. 5b, 5d and 5f and Supplementary Table S5b), the BsrV
catalytic pocket appears to accommodate all ten amino acids
found to be racemized by this enzyme (Figs. 5a, 5c and 5e).
Furthermore, in full agreement with the substrate specificity of
BsrV, the remaining nine amino acids present multiple steric
clashes when forced to fit into the active site of the enzyme
(Supplementary Fig. S5a).
The docking analysis supported two overlapping mechan-
isms for amino-acid stabilization by BsrV: one for aliphatic
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Figure 3
BsrV and Cl-BsrV active-site structures and kinetic parameters. (a) Stereoview of the BsrV
active site. Relevant residues and PLP are shown as sticks; water molecules and Cl ions are
shown as red and green spheres, respectively. (b) Stereoview showing the structural
superimposition of the active sites of wild-type BsrV (shown as a white transparency) and
Cl-BsrV (R173N174/AA) (coloured orange). No other significant changes apart from the
double mutation and consequent Cl loss (white sphere) are apparent. (c) Comparison
between the kcat of Cl-BsrV and BsrV for different racemizable amino acids. The results in
(c) are means  SD of triplicates from two independent experiments. See also Supplementary
Fig. S3.
residues and another for basic amino acids. Aliphatic amino
acids (Ala, Ser, Cys, Leu, Gln and Met) are likely to be
stabilized in the active site of BrsV through polar interactions
between their carboxylate moiety and Arg173, Tyr2990 and
Tyr3180, in a similar way to that defined for Ala in AlrBs (Figs.
5a and 5b). In addition, the amino-acid side chains are stabi-
lized through hydrophobic interactions with Met3470 in BsrV
(Figs. 5a, 5c and 5e). Basic amino acids (Arg, Lys and Orn) are
stabilized by the same interactions at their carboxylate
moieties and, in addition, by hydrogen bonding to Tyr394 and
by electrostatic interactions with Asp268 and the PLP phos-
phate group (Fig. 5e).
Furthermore, docking results neatly explain why BsrV, but
not Alrs, racemizes long aliphatic and basic residues. In Alrs,
a Tyr residue (Tyr354 in AlrBs) closes the active-site cavity,
which accommodates the short chain of the Ala residue
(Fig. 5b) but produces steric clashes when longer aliphatic, or
basic, residues are docked (Figs. 5d and 5f). The presence of a
Pro residue (Pro391) at the equivalent position in BsrV makes
sufficient additional space for the proper fitting of both long
aliphatic and basic residues (Fig. 5c and 5e).
The differential efficiency of BsrV for its substrates was also
in agreement with the docking results. Indeed, the lower
activity values found for His and Asn (Supplementary Fig.
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Figure 4
The identification of 16 residues that constitute the molecular footprint for BsrV multispecificity and experimental validation. (a) Tree of BsrV
orthologues obtained through bioinformatic sequence analysis (see x2). Alr-like enzymes are highlighted in red, Bsr-like enzymes in blue and non-Alr-
like, non-Bsr-like enzymes in green; 15 outlier proteins that do not group with any of these families are shown in black. All Bsr-like family members
(including BsrV) and a small subset of Alr-like enzymes (including AlrVand AlrEc) are listed. (b) Molecular footprint. Sequence composition (displayed
as sequence logos) of the specificity-determining positions for Alr/BsrV-like racemases. The specific residues and their positions are listed at the top. (c)
Structural analysis of the broad-spectrum racemase from A. hydrophila (BsrAh). A structural superimposition of BsrV with BsrAh is shown on the left.
Loop L2 and the -helix 10 at the entry channel are labelled. The central panel shows a close-up view of the BsrAh catalytic site. Relevant residues and
PLP are shown as sticks; water molecules and Cl ions are shown as red and green spheres, respectively. In the right box, a close-up view of the back-side
region (180 rotation view) of BsrAh with the N-terminal insertion in stick representation is shown. Polar interactions between relevant residues of the
N-terminal extensions from both monomers are represented as dotted lines. See also Supplementary Fig. S4.
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Figure 5
DAA recognition by BsrV from V. cholerae versus Alr from B. stearothermophilus. Docked models of enzyme–substrate catalytic intermediates (BsrV
and AlrBs) for (a, b) short non--branching residues (d-Ala, shown in stick representation with C atoms coloured blue) (1*), (c, d) long non--branching
residues (d-Met, shown in stick representation with C atoms coloured magenta) (2*) and (e, f) positively charged residues (d-Arg, shown in stick
representation with C atoms coloured yellow) (3*). Protein residues involved in substrate recognition are labelled and interactions are highlighted as
dotted lines. Substrates clashes are labelled by an asterisk. (g) Schematic of specific activity (relative to wild-type BsrV; left column) of BsrV single
mutants in the ‘signature’ SDP. The results correspond to means of triplicates. (h) Location of the SDP within the BrsV structure. See also
Supplementary Fig. S5.
S1g) can be explained by the limited interactions with Asp268
owing to their shorter side chains (Supplementary Figs. S5c
and S5d). Nonetheless, additional elements seem to partici-
pate in the stabilization of basic substrates.
3.8. Functional verification of the putative specificity
determinants of BsrV
To further understand the different specifities of BsrV and
AlrVand to assess the significance of each ‘signature’ residue,
we examined the activity of purified BsrV containing indivi-
dual point mutations at these loci (Figs. 5g and 5h and
Supplementary Figs. S5f and S5g). Notably, the mutation of
any of the signature sites reduced the activity of BsrV,
although the extent of the reduction varied among the
mutations and among the classes of substrates (i.e. short and
long non--branching aliphatic chains versus positively
charged side chains; Fig. 5g and Supplementary S5g). Struc-
tural analysis provides likely explanations for the effects of
these mutations on BsrV activity (Fig. 5h and Table 3). The
analysis of the activity of each BsrV mutant isoform revealed
that five substitutions (R119A, R121A, A165K, N167A and
Y208A) reduced the activity below 20% compared with wild-
type BsrV for most of the substrates (Fig. 5g). The footprint
residues Arg119 and Arg121 are involved in salt-bridge
interactions on the back side of the dimer and allow the
formation of the N-terminal extension of BsrV. The dramatic
effect of their absence confirms our previous conclusion
(based on the P25E mutant) that the N-terminal extension is
critical for the activity of BsrV towards a variety of substrates.
In contrast, the A165K and N167A substitutions are expected
to impair Cl coordination and consequently the stabilization
of the catalytic Arg173. Finally, the Y208A mutant should
affect the conformation of the entry loop L1 (Table 3) and, as
expected, has an especially large effect
on the racemization of amino acids with
long side chains.
The remaining substitutions have
narrower effects, and most frequently
limit the activity of BsrV towards long
non--branching amino acids, possibly
because these substrates encounter
more steric obstacles in entering and/or
being positioned within the active site.
Interestingly, a subset of mutations
(G169A, N174A and P391N) that
prevent the racemization of non--
branching aliphatic amino acids do not
markedly impair the activity of BsrV
towards basic substrates. Based on the
docking models, it seems likely that the
side chains of basic substrates are
stabilized by different components
within the catalytic site (e.g. PLP,
Asp268 and Tyr394; Fig. 5e). Analysis of
a D268N mutant further confirmed that
Asp268 contributes to the racemization of basic amino acids
by BsrV (Supplementary Fig. S5e).
4. Discussion
Broad-spectrum amino-acid racemases such as BsrV enable
bacteria to generate NCDAA, the varied roles of which in
microbial physiology are just beginning to be appreciated
(Cava, de Pedro et al., 2011; Kolodkin-Gal et al., 2010, 2012;
Lam et al., 2009). Here, we present extensive crystallographic,
biochemical and bioinformatic analyses of two broad-
spectrum racemases (BsrV and BsrAh) and identify the struc-
tural features that enable such enzymes to accommodate a
wider range of substrates than related PLP-dependent alanine
racemases. We also identify the molecular signature for BsrV-
like racemases from diverse microbes that enables them to be
distinguished from monospecific alanine racemases.
Although BsrV from V. cholerae has previously been
reported to produce primarily d-Met and d-Leu (Lam et al.,
2009), we found that this enzyme can also racemize eight
additional amino acids typically found in proteins, as well as
several nonproteinogenic amino acids. The substrates of BrsV
fall into two main classes: non--branched aliphatic amino
acids (i.e. Ala, Ser, Leu, Cys, Gln, Asn and Met) and basic
amino acids (i.e. Arg, Lys and His). Although d forms of the
latter class were not detected in vivo, kinetic analyses indicate
that they can be readily generated by BsrV, perhaps facilitated
by additional stabilizing interactions between these substrates
and the active site of BsrV (Figs. 5a, 5c and 5e). Lys and Arg
have also been found to be the preferred substrates of a
broad-spectrum periplasmic racemase from Pseudomonas
taetrolens (Matsui et al., 2009). The enhanced active-site
stabilization predicted for basic substrates may account for the
resilience of the catalytic activity of mutant BsrV with such
substrates relative to large uncharged aliphatic substrates
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Table 3
Structural analysis of the molecular footprint of BrsV.
Mutation Protein region Structural explanation
C70A Active site Structural stabilization of active site by a disulfide bridge
R119A N-terminal insertion Arg119 is involved in salt-bridge interactions allowing
N-terminal insertion in BsrV
R121A N-terminal insertion Arg121 is involved in salt-bridge interactions allowing
N-terminal insertion in BsrV
A165K Active site Ala at this position allows the correct stabilization of the Cl
ion by Arg173 and Asn174 (in Alrs, this position is
occupied by the N-carboxylated Lys)
N167A Active site Structural stabilization of loop involved in Cl coordination
G169A Active site Loop involved in Cl coordination
N174A Active site Residue involved in Cl coordination
P206N Entry loops Structural stabilization of the L1 loop (involved in substrate
entry)
Y208A Entry loops Stabilization of the PLP phosphate group
K216A Entry loops Salt-bridge interaction stabilizing 10 at the entry
Y246A Entry loops Mutation will block movement of the r2 region
G263I Active site Gly residue allows Asp268 and Tyr394 stabilization of side
chains of different substrates
N348A Active site Stabilization of loop that includes Met347 at the catalytic site
T349A Active site
P391N Active site This Pro is critical in the broad specificity of BsrV, allowing
the stabilization of side chains from different substrates
(Fig. 5g). The substrate range of BsrV, which includes activity
towards non-natural substrates (e.g. ornithine, norleucine,
homoserine, N-acetyl lysine methyl ester, diaminobutyrate
and aminobutyrate; Supplementary Fig. S1e), is broader than
any other known amino-acid racemase and suggests that it
has great potential for biotechnological and industrial appli-
cations. Currently, production of DAA is an expensive process
that is typically reliant upon inefficient chemical catalysts
(Gong et al., 2010; Green et al., 2009; Toth & Richard, 2007).
Interestingly, all of the Bsr-family racemases are encoded by
Gram-negative bacteria. Since some Gram-positive organisms
(e.g. B. subtilis) have also been reported to produce NCDAA,
this result suggests that additional families of broad-spectrum
enzymes may remain to be identified. Consistent with this
idea, the spectrum of NCDAA produced by B. subtilis
includes several amino acids that cannot be generated by BsrV
(e.g. d-Tyr and d-Trp; Kolodkin-Gal et al., 2010). Additional
broad-spectrum enzymes may not be related to the PLP-
dependent racemases such as Alrs and Bsrs, but might instead
bear a resemblance to other known racemases, such as MurI.
Comparative structural analyses of BsrV-family broad-
spectrum racemases (BsrV and BsrAh) and more restricted
enzymes (AlrAh, AlrEc and AlrBs) suggest that the catalytic
plasticity of these racemases has three essential determinants:
the arrangement and features of the entry site, the width of the
channel leading to the active site and its catalytic environment,
which is able to accommodate and stabilize substrates of
diverse chemical natures. There is no indication that the
underlying mechanism of racemization differs between the
two enzyme subfamilies since the dominant catalytic moeties
(catalytic Lys and Tyr) are found in both. The wider entry site
and channel of BsrV are likely to facilitate interaction with
amino-acid substrates larger than alanine; indeed, structural,
biochemical and modelling analyses suggest that the entry
channel of BrsV can also accommodate peptide chains which
are markedly larger. The catalytic site of BsrV-like racemases
is also less constrained than those of related alanine race-
mases, apparently owing both to differences in the compo-
nents of the chambers (e.g. Cl and Pro391) and to different
arrangements of the enzymatic domains that interact to form
them. Previous analyses have revealed variability in the rela-
tive positioning of racemase N- and C-terminal domains owing
to changes in the amino acids at the dimer interface (Coun˜ago
et al., 2009). In broad-spectrum racemases, this interface is
markedly altered by the presence of a new structure formed
from an extended N-terminal sequence. Mutational analyses
indicate that the N-terminal extension, as well as the 16
‘signature’ amino acids that can be used to identify broad-
spectrum enzymes, are critical for racemase activity on the full
set of substrates. Interestingly, mutations in most signature loci
did not revert BsrV to an alanine-specific racemase; instead,
its activity towards large aliphatic side chains was often lost,
while its activity towards basic amino acids was preserved.
Collectively, given the impact of NCDAA on a variety of
cellular processes [e.g. biofilm stability, sporulation and cell
communication (Anfora et al., 2007; Kolodkin-Gal et al., 2010;
O’Connor & Zusman, 1997)], structural and regulatory
characterization of broad-spectrum racemases might open the
door to the design of new drugs (Conti et al., 2011) that would
challenge the adaptability of pathogenic bacteria to adverse
conditions (i.e. during infection).
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